Liu David Y 4
4 · Protagonist Therapeutics, Inc · Filed Mar 2, 2022
Insider Transaction Report
Form 4
Liu David Y
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2022-02-28$24.28/sh−2,119$51,449→ 66,538 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 6,125 vested restricted stock units on February 28, 2022.